Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADVR:THE NEW COMPANY...WITH A NEW LIFE...AND A NEW MISSION -- Ignore unavailable to you. Want to Upgrade?

To: BARRY ALLEN who wrote (294)	6/4/1998 2:21:00 AM
From: RickV	Respond to of 4891

barry with allthese posts you print i would one day soon hope to see advr in the caption instead of all these other companies... rick

To: BARRY ALLEN who wrote (294)	6/4/1998 6:35:00 AM
From: OLD JAKE JUSTUS	Respond to of 4891

Barry, I do hope all of the readers noticed the serious side effects of this new drug. So far as I know, Reticulcose has no known serious side effects and it is 100% safe to use for human consumption. In addition, it is very inexpensive for the consumer to use it.

To: BARRY ALLEN who wrote (294)	6/4/1998 9:54:00 AM
From: Bernie Bildman	Read Replies (1) \| Respond to of 4891

So far as I know, Rebetron has been _APPROVED_ by the FDA for the treatment of Hepatitis C. Reticulose, far as I can surmise, isn't slightly close to being approved for even _TESTING_ (by the US FDA) for any malady at this point in time. I say this only to point out it doesn't do us much good to talk about all the "serious side effects" of other drugs. At least other companies are moving along in the test and approval process, something which Reticulose doesn't seem to be doing. If they are, we sure aren't being told about it.